Clinical Trials in Portland

Showing 3241-3260 of 10,048 trials

Post-Market Clinical Investigation of the IotaSOFT Insertion System

NCT06664697

The purpose of the proposed study is to evaluate the continued safety of the iotaSOFT Insertion System when used by a surgeon to assist with inserting a CI electrode array in one ear per subject

Hearing Loss, CochlearCochlear ImplantationHearing Loss, Sensorineural

iotaMotion, Inc.50 participantsStarted Oct 2024

Indianapolis, Indiana, United States • Iowa City, Iowa, United States • Portland, Oregon, United States

COMPLETEDPhase 1< 1 mile

A Study to Test the Safety of the Investigational Drug Selitrectinib in Children and Adults That May Treat Cancer

NCT03215511

This research study is done to test the safety of the new drug selitrectinib in children and adults with cancer having a change in a particular gene (NTRK1, NTRK2 or NTRK3). The drug may treat cancer by interfering with the effect of the NTRK genes on cancer growth. The study also investigates how the drug is absorbed and processed in the human body, and how well and for how long the cancer responds to the drug. This is the first study to test selitrectinib in humans with cancer, for whom no other effective therapy exists.

Solid Tumors Harboring NTRK Fusion

Bayer81 participantsStarted Jul 2017

La Jolla, California, United States • Los Angeles, California, United States • Palo Alto, California, United States +26 more locations

Post-Market Clinical Investigation of the IotaSOFT Insertion System

A Study to Test the Safety of the Investigational Drug Selitrectinib in Children and Adults That May Treat Cancer

Find Trials by Condition in Portland

GTSCOPE - To Evaluate the Natural Progression of Dry Age-related Macular Degeneration (AMD)

A Study to Assess the Analgesic Efficacy and Safety of ASP0819 in Patients With Fibromyalgia

Study of BGB-290 or Placebo in Participants With Advanced or Inoperable Gastric Cancer

Brief Virtual Mindfulness-based Group Intervention with Social Support for Perinatal Individuals

A Study to Assess the Safety, Pharmacokinetics and Effectiveness of AGS-16C3F Monotherapy in Subjects With Renal Cell Carcinoma (RCC) of Clear Cell or Papillary Histology

Entyvio (Vedolizumab) Long Term Safety Study

A Dose Determination and Safety Study of X4P-001 (Mavorixafor) in Participants With Warts, Hypogammaglobulinemia, Infections, and Myelokathexis (WHIM) Syndrome

Glasdegib for Chronic Graft-Versus-Host Disease

The PRISM Intervention for Adolescents and Young Adults Receiving Hematopoietic Cell Transplantation

Study of Novel Regimens in Relapsed or Refractory Multiple Myeloma

First-in-Human (FIH) Trial of GEN3009 in Subjects With Relapsed or Refractory B-Cell Non-Hodgkin Lymphomas

A Phase 3 Safety and Efficacy Study of Fovista® (E10030) Intravitreous Administration in Combination With Lucentis® Compared to Lucentis® Monotherapy

A Trial Comparing Combination Treatment (Solifenacin Plus Mirabegron) With One Treatment Alone (Solifenacin)

Study of BGB-A317 in Participants With Relapsed or Refractory Mature T- and NK-cell Neoplasms

A Study to Evaluate the Safety, Tolerability, and Immunogenicity of V116 in Pneumococcal Vaccine-experienced Adults (V116-006, STRIDE-6)

A Study of Escalating Doses of ASG-22CE Given as Monotherapy in Subjects With Metastatic Urothelial Cancer and Other Malignant Solid Tumors That Express Nectin-4

A Study of TAK-994 in Adults With Type 1 and Type 2 Narcolepsy

Utility of Donor-Derived Cell Free DNA in Association With Gene Expression Profiling